Post-marketing Drug Safety Evaluation Using Data Mining Based on FAERS. - Rui Duan 004; Xinyuan Zhang 003; Jingcheng Du; Jing Huang 021; Cui Tao; Yong Chen 016 (DMBD, 2017)

Comparing Different Adverse Effects Among Multiple Drugs Using FAERS Data. - Jing Huang 021; Xinyuan Zhang 003; Jingcheng Du; Rui Duan 004; Liu Yang; Jason H. Moore; Yong Chen 016; Cui Tao (MedInfo, 2017)

Comparing adverse effects of Hepatitis C drugs using FAERS data. - Jing Huang 021; Xinyuan Zhang 003; Jiayi Tong; Jingcheng Du; Rui Duan 004; Liu Yang; Jason H. Moore; Yong Chen 016; Cui Tao (BIBM, 2018)

Comparing Pharmacovigilance Outcomes Between FAERS and EMR Data for Acute Mania Patients. - Xinyuan Zhang 003; Rui Duan 004; Jingcheng Du; Jing Huang 021; Yong Chen 016; Cui Tao (ICHI Workshops, 2018)

Collective feature selection to identify crucial epistatic variants. - Shefali S. Verma; Anastasia Lucas; Xinyuan Zhang 003; Yogasudha Veturi; Scott M. Dudek; Binglan Li; Ruowang Li; Ryan J. Urbanowicz; Jason H. Moore; Dokyoon Kim; Marylyn D. Ritchie (BioData Min., 2018)

Detecting potential pleiotropy across cardiovascular and neurological diseases using univariate, bivariate, and multivariate methods on 43, 870 individuals from the eMERGE network. - Xinyuan Zhang 003; Yogasudha Veturi; Shefali Setia Verma; William Bone; Anurag Verma; Anastasia Lucas; Scott J. Hebbring; Joshua C. Denny; Ian B. Stanaway; Gail P. Jarvik; David R. Crosslin; Eric B. Larson; et al. (PSB, 2019)

Real world scenarios in rare variant association analysis: the impact of imbalance and sample size on the power in silico. - Xinyuan Zhang 003; Anna Okula Basile; Sarah A. Pendergrass; Marylyn D. Ritchie (BMC Bioinform., 2019)

Comparing drug safety of hepatitis C therapies using post-market data. - Jing Huang 021; Xinyuan Zhang 003; Jiayi Tong; Jingcheng Du; Rui Duan 004; Liu Yang; Jason H. Moore; Cui Tao; Yong Chen 016 (BMC Medical Informatics Decis. Mak., 2019)

Statistical Impact of Sample Size and Imbalance on Multivariate Analysis in silico and A Case Study in the UK Biobank. - Xinyuan Zhang 003; Ruowang Li; Marylyn D. Ritchie (AMIA, 2020)

On the evidence consistency of pharmacovigilance outcomes between Food and Drug Administration Adverse Event Reporting System and electronic medical record data for acute mania patients. - Rui Duan 004; Xinyuan Zhang 003; Jingcheng Du; Jing Huang 021; Cui Tao; Yong Chen 016 (Health Informatics J., 2020)

Developing Ontologies to Standardize Descriptions of Visual and Dermoscopic Elements. - Rebecca Z. Lin; Muhammad Tuan Amith; Xinyuan Zhang 003; Cynthia Wang; Jeremy Light; John Strickley; Cui Tao (BIBM, 2021)

DEVO: an ontology to assist with dermoscopic feature standardization. - Xinyuan Zhang 003; Rebecca Z. Lin; Muhammad Tuan Amith; Cynthia Wang; Jeremy Light; John Strickley; Cui Tao (BMC Medical Informatics Decis. Mak., 2023)

Evaluating MedDRA-to-ICD terminology mappings. - Xinyuan Zhang 003; Yixue Feng 001; Fang Li 011; Jin Ding; Danyal Tahseen; Ezekiel Hinojosa; Yong Chen 016; Cui Tao (BMC Medical Informatics Decis. Mak., 2024)